Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
2
×
national blog main
akcea therapeutics
anylam pharmaceuticals
biotech
boston blog main
boston top stories
cardiomyopathy
clinical trials
deals
drugs
fda
food and drug administration
inotersen
medical device
national top stories
neuropathy
new york
new york blog main
new york top stories
onpattro
patisiran
pfizer
pulmonary arterial hypertension
raleigh-durham blog main
san diego blog main
san diego top stories
san francisco
san francisco blog main
san francisco top stories
startups
steadymed
tafamidis
tegsedi
transthyretin amyloidosis
treprostinil
united therapeutics
What
disease
2
×
drug
rare
2
×
ago
akcea
alnylam
amyloidosis
approved
attr
available
battle
building
deal
debilitating
developer
established
fda
firm
genetic
lung
medicines
momentum
oks
pah
patients
pfizer
reaches
rivalry
seller
sets
steadymed
therapeutics
therapy
transthyretin
united
year
Language
Current search:
rare
×
disease
×
" life sciences "
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed